On October 30, Illumina fell 10.84% in Pre-Market Trading, trading at $258.0/share, with turnover of $54.8 thousand.
The move followed the company’s latest quarterly report, where adjusted EPS of $1.62 topped the $1.36 market expectation and full-year adjusted operating margin guidance was raised to 23.6%, while organic revenue growth guidance of more than 4% was maintained.
However, investors focused more on the softer top line. Quarterly revenue was reported at about $1.129 billion, below the roughly $1.154 billion consensus, and China revenue declined 0.1% in the quarter. Other disclosed figures showed free cash flow rose to $378 million from $253 million a year earlier, but the revenue miss and regional pressure appear to have outweighed the profit beat and improved outlook in the market reaction.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments